Dublin-based generic drugmaker, specialty drug supplier, and medical imaging agent producer Mallinckrodt Plc increases its presence in U.S. hospitals by buying privately held Ikaria Inc, a maker of a respiratory drug and its delivery system, for $2.3 billion from a group of investors led by private equity firm Madison Dearborn Partners LLC. The deal includes INOmax, which is the only approved product to treat hypoxic respiratory failure in infants through nitric oxide. (Reuters)